---
title: "Certolizumab Pegol - Ankylosing Spondylitis"
sidebar: mydoc_sidebar
permalink: db08904-mesh-d013167-1.html
toc: false 
---


Path ID: `DB08904_MESH_D013167_1`
{% include image.html url="images/db08904-mesh-d013167-1.png" file="db08904-mesh-d013167-1.png" alt="db08904-mesh-d013167-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D000068582">MESH:D000068582 </a> | Certolizumab pegol | Drug |
| <a href="https://identifiers.org/UniProt:P01375">UniProt:P01375 </a> | Tumor necrosis factor | Protein |
| <a href="https://identifiers.org/reactome:R-HSA-75893">reactome:R-HSA-75893 </a> | TNF signaling | Pathway |
| <a href="https://identifiers.org/GO:0006954">GO:0006954 </a> | Inflammatory response | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D013167">MESH:D013167 </a> | Ankylosing spondylitis | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Certolizumab Pegol | DECREASES ACTIVITY OF | Tumor Necrosis Factor |
| Tumor Necrosis Factor | PARTICIPATES IN | Tnf Signaling |
| Tnf Signaling | POSITIVELY REGULATES | Inflammatory Response |
| Inflammatory Response | CAUSES | Ankylosing Spondylitis |
|---------|-----------|---------|

Reference: 
  - [https://en.wikipedia.org/wiki/Ankylosing_spondylitis](https://en.wikipedia.org/wiki/Ankylosing_spondylitis)
  - [https://go.drugbank.com/drugs/DB08904](https://go.drugbank.com/drugs/DB08904)
